MORGENS WATERFALL VINTIADIS & CO INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGENS WATERFALL VINTIADIS & CO INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,175,000
+62.7%
50,000
+28.2%
0.80%
+44.0%
Q3 2019$722,000
-0.4%
39,0000.0%0.55%
+11.0%
Q2 2019$725,000
-23.9%
39,0000.0%0.50%
-26.8%
Q1 2019$953,000
-5.8%
39,0000.0%0.68%
-24.2%
Q4 2018$1,012,000
-18.0%
39,0000.0%0.90%
+11.5%
Q3 2018$1,234,000
-18.5%
39,0000.0%0.81%
-24.8%
Q2 2018$1,515,00039,0001.07%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders